AU2002249740A1 - Medicament and method for diagnosing an autoimmune condition_in particular psoriasis - Google Patents

Medicament and method for diagnosing an autoimmune condition_in particular psoriasis

Info

Publication number
AU2002249740A1
AU2002249740A1 AU2002249740A AU2002249740A AU2002249740A1 AU 2002249740 A1 AU2002249740 A1 AU 2002249740A1 AU 2002249740 A AU2002249740 A AU 2002249740A AU 2002249740 A AU2002249740 A AU 2002249740A AU 2002249740 A1 AU2002249740 A1 AU 2002249740A1
Authority
AU
Australia
Prior art keywords
diagnosing
medicament
autoimmune condition
particular psoriasis
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249740A
Inventor
Colin Dykes
Duncan Hewett
Ian Purvis
Gunnar Swanbeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESTETECON AB
Original Assignee
ESTETECON AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0108589A external-priority patent/GB0108589D0/en
Priority claimed from GB0108590A external-priority patent/GB0108590D0/en
Priority claimed from GB0108587A external-priority patent/GB0108587D0/en
Application filed by ESTETECON AB filed Critical ESTETECON AB
Publication of AU2002249740A1 publication Critical patent/AU2002249740A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2002249740A 2001-04-05 2002-04-04 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis Abandoned AU2002249740A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0108589A GB0108589D0 (en) 2001-04-05 2001-04-05 Therapeutic agent
GB0108589.3 2001-04-05
GB0108590A GB0108590D0 (en) 2001-04-05 2001-04-05 Medicament
GB0108590.1 2001-04-05
GB0108587A GB0108587D0 (en) 2001-04-05 2001-04-05 Diagnosis
GB0108587.7 2001-04-05
PCT/SE2002/000669 WO2002080842A2 (en) 2001-04-05 2002-04-04 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis

Publications (1)

Publication Number Publication Date
AU2002249740A1 true AU2002249740A1 (en) 2002-10-21

Family

ID=27256138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002249740A Abandoned AU2002249740A1 (en) 2001-04-05 2002-04-04 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis

Country Status (2)

Country Link
AU (1) AU2002249740A1 (en)
WO (1) WO2002080842A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248248A1 (en) * 2001-03-30 2004-12-09 Marion Webster Isolated human transporters proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CA2519241A1 (en) * 2003-04-01 2004-11-11 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2009070113A1 (en) * 2007-11-28 2009-06-04 Redoxis Aktiebolag New treatment of autoimmune conditions
CN115397519A (en) * 2019-07-24 2022-11-25 艾吉纳斯公司 Antigenic polypeptides and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2274955A1 (en) * 1996-12-31 1998-07-09 Yale University Method to diagnose and treat pathological conditions resulting from deficient ion transport such as bartter's syndrome and gitelman's syndrome

Also Published As

Publication number Publication date
WO2002080842A3 (en) 2003-01-23
WO2002080842A2 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
WO2002077813A8 (en) Development and testing system and method
AU5925199A (en) External stress reduction device and method
AU2003282580A1 (en) Contrast therapy system and method
AU2003291001A1 (en) Integrated medical knowledge base interface system and method
AU5139900A (en) Liposome-enhanced test device and method
AU2001250957A1 (en) Integrated capacitor-like battery and associated method
AU2001252988A1 (en) Performance monitor system and method suitable for use in an integrated circuit
AU2003268369A1 (en) Performance monitor and method therefor
AU2003245157A1 (en) Telehealth system and method
AU2001262986A1 (en) Systems and methods for diagnosing faults in computer networks
AU2003258396A1 (en) System and method for integrated circuit design
AU2002357273A1 (en) Cache storage system and method
AU2002360520A1 (en) Power reduction measurement system and method
AU2003288370A1 (en) Integrated software and method for authenticating same
AU2002307198A1 (en) System and method for testing linkages
AU2003269731A1 (en) Regasification system and method
AU2003243617A1 (en) An inspection system and method
AU2003202387A1 (en) Lottery method and system
AU2003268638A1 (en) Sharging method and charging system
AU2002249740A1 (en) Medicament and method for diagnosing an autoimmune condition_in particular psoriasis
AU2002227837A1 (en) Method and system for diagnosing andropause in males
AUPR647101A0 (en) An evaluation system and method therefor
AU2003266601A1 (en) Connection method and connection device
AU2003265366A1 (en) Recharging method and apparatus
AU2003289282A1 (en) Diagnosis device and diagnosis method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase